Skip to Content

Vaccines, Volume 4, Issue 3

2016 September - 11 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (11)

  • Article
  • Open Access
21 Citations
6,670 Views
13 Pages

Ag85A DNA Vaccine Delivery by Nanoparticles: Influence of the Formulation Characteristics on Immune Responses

  • Johanna Poecheim,
  • Christophe Barnier-Quer,
  • Nicolas Collin and
  • Gerrit Borchard

12 September 2016

The influence of DNA vaccine formulations on immune responses in combination with adjuvants was investigated with the aim to increase cell-mediated immunity against plasmid DNA (pDNA) encoding Mycobacterium tuberculosis antigen 85A. Different ratios...

(This article belongs to the Special Issue Nanoparticles to Co-Deliver Immunopotentiators and Antigens)
  • Review
  • Open Access
65 Citations
14,717 Views
21 Pages

9 September 2016

Neutrophils are the most abundant circulating blood cell type in humans, and are the first white blood cells recruited at the inflammation site where they orchestrate the initial immune response. Although their presence at the tumor site was recogniz...

(This article belongs to the Special Issue Mechanisms of Tumor Escape from Host Immunity)
  • Review
  • Open Access
26 Citations
7,023 Views
13 Pages

T-Regulatory Cells and Vaccination “Pay Attention and Do Not Neglect Them”: Lessons from HIV and Cancer Vaccine Trials

  • Vedran Brezar,
  • Véronique Godot,
  • Liang Cheng,
  • Lishan Su,
  • Yves Lévy and
  • Nabila Seddiki

5 September 2016

Efficient vaccines are characterized by the establishment of long-lived memory T cells, including T-helper (effectors and follicular) and T-regulatory cells (Tregs). While the former induces cytotoxic or antibody responses, the latter regulates immun...

(This article belongs to the Special Issue T Cell Memory to Vaccination)
  • Review
  • Open Access
18 Citations
9,274 Views
23 Pages

Monitoring of the Immune Dysfunction in Cancer Patients

  • Saskia J. A. M. Santegoets,
  • Marij J. P. Welters and
  • Sjoerd H. Van der Burg

2 September 2016

Immunotherapy shows promising clinical results in patients with different types of cancer, but its full potential is not reached due to immune dysfunction as a result of several suppressive mechanisms that play a role in cancer development and progre...

(This article belongs to the Special Issue Mechanisms of Tumor Escape from Host Immunity)
  • Review
  • Open Access
467 Citations
23,491 Views
25 Pages

Recent years have seen significant efforts in understanding and modulating the immune response in cancer. In this context, immunosuppressive cells, including regulatory T cells (Tregs) and myeloid-derived suppressor cells (MDSCs), have come under int...

(This article belongs to the Special Issue Mechanisms of Tumor Escape from Host Immunity)
  • Article
  • Open Access
36 Citations
8,654 Views
28 Pages

Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic Infection

  • Leo Swadling,
  • John Halliday,
  • Christabel Kelly,
  • Anthony Brown,
  • Stefania Capone,
  • M. Azim Ansari,
  • David Bonsall,
  • Rachel Richardson,
  • Felicity Hartnell and
  • Eleanor Barnes
  • + 11 authors

An effective therapeutic vaccine for the treatment of chronic hepatitis C virus (HCV) infection, as an adjunct to newly developed directly-acting antivirals (DAA), or for the prevention of reinfection, would significantly reduce the global burden of...

(This article belongs to the Special Issue T Cell Memory to Vaccination)
  • Review
  • Open Access
67 Citations
12,342 Views
13 Pages

Aberrantly glycosylated mucin 1 (MUC1) is a recognized tumor-specific antigen on epithelial cell tumors. A wide variety of MUC1 glycopeptide anti-cancer vaccines have been formulated by many research groups. Some researchers have used MUC1 alone as a...

(This article belongs to the Special Issue Glycopeptide-based and Related Vaccines)
  • Review
  • Open Access
139 Citations
13,556 Views
17 Pages

Leptin-Induced JAK/STAT Signaling and Cancer Growth

  • McKay Mullen and
  • Ruben Rene Gonzalez-Perez

Growth factor and cytokine signaling can influence the development of several cancer types. One of the key players in the development of cancer is the Janus kinas (JAK) signal transducer of activators of transcription (STAT) signaling pathway. The ma...

  • Article
  • Open Access
7 Citations
5,718 Views
10 Pages

This study examined the influences of the dosage of the adjuvant, the nature of the antigen and the host genetics on the capacity of L. fermentum PC1 (PC1) to function as an oral adjuvant. BALB/c and DBA/1 mice were vaccinated with either ovalbumin (...

  • Review
  • Open Access
110 Citations
20,127 Views
26 Pages

The interferon (IFN) induced anti-viral response is amongst the earliest and most potent of the innate responses to fight viral infection. The induction of the Janus kinase/signal transducer and activation of transcription (JAK/STAT) signalling pathw...

  • Review
  • Open Access
362 Citations
27,170 Views
15 Pages

The IL-8/IL-8R Axis: A Double Agent in Tumor Immune Resistance

  • Justin M. David,
  • Charli Dominguez,
  • Duane H. Hamilton and
  • Claudia Palena

Interleukin-8 (IL-8, CXCL8) is a pro-inflammatory chemokine produced by various cell types to recruit leukocytes to sites of infection or tissue injury. Acquisition of IL-8 and/or its receptors CXCR1 and CXCR2 are known to be a relatively common occu...

(This article belongs to the Special Issue Mechanisms of Tumor Escape from Host Immunity)
XFacebookLinkedIn
Vaccines - ISSN 2076-393X